Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Jul 1, 2026
Sale
Shares
28,684
Price
$5.42
Total Value
$155.47K
Shares Held After
6,122,472
% of Holdings
0.5%
Jul 1, 2026
Purchase
Shares
20,000
Price
$1.98
Total Value
$39.60K
Shares Held After
356,904
% of Holdings
5.6%

Adaptive Biotechnologies Corp (ADPT)

LO FRANCIS — Chief People Officer
Jul 1, 2026
Sale
Shares
42,261
Price
$22.50
Total Value
$950.87K
Shares Held After
237,688
% of Holdings
15.1%

Adaptive Biotechnologies Corp (ADPT)

LO FRANCIS — Chief People Officer
Jul 1, 2026
Sale
Shares
8,743
Price
$22.18
Total Value
$193.92K
Shares Held After
279,949
% of Holdings
3.0%

Adaptive Biotechnologies Corp (ADPT)

BOBULSKY SUSAN — Chief Commercial Officer, MRD
Jul 1, 2026
Sale
Shares
487
Price
$22.00
Total Value
$10.71K
Shares Held After
406,288
% of Holdings
0.1%
Jul 1, 2026
Sale
Shares
4,177
Price
$18.44
Total Value
$77.02K
Shares Held After
3,202,131
% of Holdings
0.1%

AdaptHealth Corp. (AHCO)

Schuster III Russell E. — Chief Commercial Officer
Jul 1, 2026
Sale
Shares
11,275
Price
$10.44
Total Value
$117.71K
Shares Held After
125,263
% of Holdings
8.3%
Jul 1, 2026
Sale
Shares
11,419
Price
$79.04
Total Value
$902.55K
Shares Held After
11,014
% of Holdings
50.9%
Jul 1, 2026
Sale
Shares
99
Price
$79.45
Total Value
$7.87K
Shares Held After
22,433
% of Holdings
0.4%
Shares
130,000
Price
$30.50
Total Value
$3.96M
Shares Held After
633,455
% of Holdings
17.0%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Jul 1, 2026
Sale
Shares
6
Price
$57.82
Total Value
$346.92
Shares Held After
156,760
% of Holdings
0.0%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Jul 1, 2026
Sale
Shares
456
Price
$57.47
Total Value
$26.21K
Shares Held After
156,766
% of Holdings
0.3%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Jul 1, 2026
Sale
Shares
1,788
Price
$56.03
Total Value
$100.18K
Shares Held After
157,222
% of Holdings
1.1%
Jul 1, 2026
Sale
Shares
6,000
Price
$240.47
Total Value
$1.44M
Shares Held After
366,682
% of Holdings
1.6%
Jul 1, 2026
Sale
Shares
30,228
Price
$31.65
Total Value
$956.72K
Shares Held After
0
% of Holdings
100.0%
Jul 1, 2026
Sale
Shares
13,672
Price
$30.80
Total Value
$421.10K
Shares Held After
30,228
% of Holdings
31.1%
Jul 1, 2026
Sale
Shares
3,600
Price
$29.50
Total Value
$106.20K
Shares Held After
43,900
% of Holdings
7.6%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
Jul 1, 2026
Sale
Shares
828
Price
$502.71
Total Value
$416.24K
Shares Held After
19,131
% of Holdings
4.1%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Jul 1, 2026
Sale
Shares
500
Price
$33.27
Total Value
$16.63K
Shares Held After
27,598
% of Holdings
1.8%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Jul 1, 2026
Sale
Shares
6,728
Price
$32.62
Total Value
$219.43K
Shares Held After
28,098
% of Holdings
19.3%

Zai Lab Ltd (ZLAB)

GAYNOR RICHARD — Director
Jul 1, 2026
Purchase
Shares
1,736
Price
$19.05
Total Value
$33.07K
Shares Held After
80,737
% of Holdings
2.2%

Liquidia Corp (LQDA)

Bloch Stephen M — Director
Jul 1, 2026
Sale
Shares
853
Price
$80.05
Total Value
$68.28K
Shares Held After
855,073
% of Holdings
0.1%

Liquidia Corp (LQDA)

Bloch Stephen M — Director
Jul 1, 2026
Sale
Shares
24,147
Price
$79.45
Total Value
$1.92M
Shares Held After
855,926
% of Holdings
2.7%
Jul 1, 2026
Sale
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%
Jul 1, 2026
Sale
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%

Nuvalent, Inc. (NUVL)

Noci Darlene — Chief Development Officer
Jul 1, 2026
Sale
Shares
23,000
Price
$123.59
Total Value
$2.84M
Shares Held After
58,117
% of Holdings
28.4%

Intellia Therapeutics, Inc. (NTLA)

Dube Michael P — VP, Chief Accounting Officer
Jul 1, 2026
Sale
Shares
2,641
Price
$16.78
Total Value
$44.32K
Shares Held After
66,886
% of Holdings
3.8%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
600
Price
$317.15
Total Value
$190.29K
Shares Held After
41,514
% of Holdings
1.4%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
900
Price
$315.78
Total Value
$284.20K
Shares Held After
42,114
% of Holdings
2.1%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
100
Price
$314.58
Total Value
$31.46K
Shares Held After
43,014
% of Holdings
0.2%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
700
Price
$313.46
Total Value
$219.42K
Shares Held After
43,114
% of Holdings
1.6%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
1,081
Price
$312.28
Total Value
$337.57K
Shares Held After
43,814
% of Holdings
2.4%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
1,119
Price
$311.72
Total Value
$348.81K
Shares Held After
44,895
% of Holdings
2.4%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
104
Price
$310.20
Total Value
$32.26K
Shares Held After
46,014
% of Holdings
0.2%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
Jul 1, 2026
Sale
Shares
396
Price
$308.99
Total Value
$122.36K
Shares Held After
46,118
% of Holdings
0.9%
Jul 1, 2026
Sale
Shares
12,942
Price
$22.67
Total Value
$293.44K
Shares Held After
411,861
% of Holdings
3.0%
Jul 1, 2026
Sale
Shares
12,944
Price
$22.70
Total Value
$293.79K
Shares Held After
411,861
% of Holdings
3.0%

Inogen Inc (INGN)

Yi Boyer Jennifer M — EVP Entrprs Enblmnt, Ch HR Off
Jul 1, 2026
Sale
Shares
10,938
Price
$6.60
Total Value
$72.15K
Shares Held After
5,039
% of Holdings
68.5%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Jul 1, 2026
Sale
Shares
11,175
Price
$89.31
Total Value
$998.03K
Shares Held After
9,755
% of Holdings
53.4%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Jul 1, 2026
Sale
Shares
2,801
Price
$88.51
Total Value
$247.92K
Shares Held After
20,930
% of Holdings
11.8%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Jul 1, 2026
Sale
Shares
11,024
Price
$87.33
Total Value
$962.78K
Shares Held After
23,731
% of Holdings
31.7%

CASTLE BIOSCIENCES INC (CSTL)

Oelschlager Kristen M — Chief Operating Officer
Jul 1, 2026
Sale
Shares
400
Price
$24.78
Total Value
$9.91K
Shares Held After
21,874
% of Holdings
1.8%

CASTLE BIOSCIENCES INC (CSTL)

Oelschlager Kristen M — Chief Operating Officer
Jul 1, 2026
Sale
Shares
8,186
Price
$24.40
Total Value
$199.74K
Shares Held After
22,274
% of Holdings
26.9%
Jul 1, 2026
Sale
Shares
43
Price
$54.81
Total Value
$2.36K
Shares Held After
59,511
% of Holdings
0.1%
Jul 1, 2026
Sale
Shares
1,155
Price
$54.23
Total Value
$62.63K
Shares Held After
59,554
% of Holdings
1.9%
Jul 1, 2026
Sale
Shares
1,346
Price
$53.54
Total Value
$72.07K
Shares Held After
60,709
% of Holdings
2.2%
Jul 1, 2026
Sale
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
Jul 1, 2026
Sale
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
Jul 1, 2026
Sale
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
Jul 1, 2026
Sale
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
Version: v26.7.3